Drug Trial Radar · NCT05463484
Effects of a Composition on the Oral Microbiome, pH, Nitrite/Nitrate Ratio, Elastases and Inflammation in Oral Dysbiosis
Last checked: Nov 20, 2026Latest source record: Jul 8, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
100
Actual
Start
Jul 13, 2021
Primary completion
Feb 28, 2023
Study completion Jul 15, 2023
Sponsor
- Lead sponsor
- Mucosa Innovations, S.L.Industry
- Sponsor type
- Industry
- Collaborators
- Universidad de Granada
- First posted
- Jul 19, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Supportive care
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Dysbiosis is a condition in which the normal function of an ecological net is altered. In dysbiosis a state of inflammation, a loss of hydration, a change in pH, a loss of the barrier function are all allies of key pathogens that initiate invasion and cytokine and pro-inflammatory mediators release that target other tissues and organs resulting in chronic inflammatory conditions. In health there is a cross-talk between the host and the microbiota in order to maintain and promote a state of eubiosis with a local and general health gain. Dysbiosis reversion has not been solved with the use of antibacterials, antiseptics nor antibiotics. Stop dysbiosis project is focussed on different aspects of human dysbiosis such as oral dysbiosis, skin dysbiosis, vaginal dysbiosis and cancer dysbiosis, between others including the current prospective interventional double-blind randomised clinical trial. One of the most common oral dysbiosis is periodontal and mucosa dysbiosis that courses with inflammation of the gingiva (gingivitis). This inflammation induces specific enzymes that in a later stage destroy connective tissue. The current clinical trial analyzes the effect of a composition (Saliactive ®) delivered to the oral cavity via a daily use toothpaste (YOTUEL® microbiome toothpaste) in a group of patients with oral dysbiosis.
Conditions
- Oral Dysbiosis
Interventions
Test composition Saliactive® (olive product, betaine and xylitol)Drug
Fluoridated toothpaste with Saliactive®.
PlaceboDrug
Fluoridated toothpaste without Saliactive®.
ControlDrug
Commercial Fluoridated toothpaste for gingivitis with zinc citrate.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Oral microbiota profile at baseline and after 4 monthsTime frame: 4 months
- Oral pH at baseline and after 4 monthsTime frame: 4 months
- Nitrite/Nitrate ratio at baseline and after 4 monthsTime frame: 4 months
- Elastase at baseline at 2 months and at 4 monthsTime frame: 4 months
- Bleeding index at baseline, at 2 months and at 4 monthsTime frame: 4 months
- Plaque index at baseline, at 2 months and at 4 monthsTime frame: 4 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Departamento de Estomatología, Facultad de Odontología
Granada, Spain
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.